ClinicalTrials.govpublic full text
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
infection, human immunodeficiency virus, hiv infections, long-acting cabotegravir, virologic failure, long-acting rilpivirine, antiretroviral, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908298
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.